These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31151579)

  • 1. The impact of dose algorithms on tumor control probability in intensity-modulated proton therapy for breast cancer.
    Liang X; Bradley JA; Zheng D; Rutenberg M; Mailhot Vega R; Mendenhall N; Li Z
    Phys Med; 2019 May; 61():52-57. PubMed ID: 31151579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiobiological and dosimetric impact of RayStation pencil beam and Monte Carlo algorithms on intensity-modulated proton therapy breast cancer plans.
    Rana S; Greco K; Samuel EJJ; Bennouna J
    J Appl Clin Med Phys; 2019 Aug; 20(8):36-46. PubMed ID: 31343826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive dosimetric study of Monte Carlo and pencil-beam algorithms on intensity-modulated proton therapy for breast cancer.
    Liang X; Li Z; Zheng D; Bradley JA; Rutenberg M; Mendenhall N
    J Appl Clin Med Phys; 2019 Jan; 20(1):128-136. PubMed ID: 30488548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans.
    Liang X; Penagaricano J; Zheng D; Morrill S; Zhang X; Corry P; Griffin RJ; Han EY; Hardee M; Ratanatharathom V
    Radiat Oncol; 2016 Jan; 11():10. PubMed ID: 26800883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Air Gap on Intensity-Modulated Proton Therapy Breast Plans.
    Rana S; Bennouna J
    J Med Imaging Radiat Sci; 2019 Dec; 50(4):499-505. PubMed ID: 31718922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of robust optimization in intensity-modulated proton therapy planning for head and neck cancers.
    Liu W; Frank SJ; Li X; Li Y; Park PC; Dong L; Ronald Zhu X; Mohan R
    Med Phys; 2013 May; 40(5):051711. PubMed ID: 23635259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is an analytical dose engine sufficient for intensity modulated proton therapy in lung cancer?
    Teoh S; Fiorini F; George B; Vallis KA; Van den Heuvel F
    Br J Radiol; 2020 Mar; 93(1107):20190583. PubMed ID: 31696729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetric consequences of image guidance techniques on robust optimized intensity-modulated proton therapy for treatment of breast Cancer.
    Liang X; Mailhot Vega RB; Li Z; Zheng D; Mendenhall N; Bradley JA
    Radiat Oncol; 2020 Feb; 15(1):47. PubMed ID: 32103762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases.
    Tran A; Zhang J; Woods K; Yu V; Nguyen D; Gustafson G; Rosen L; Sheng K
    Radiat Oncol; 2017 Jan; 12(1):10. PubMed ID: 28077128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of grid size on uniform scanning and IMPT plans in XiO treatment planning system for brain cancer.
    Rana S; Zheng Y
    J Appl Clin Med Phys; 2015 Sep; 16(5):447–456. PubMed ID: 26699310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric evaluation of photons versus protons in postmastectomy planning for ultrahypofractionated breast radiotherapy.
    Oonsiri P; Nantavithya C; Lertbutsayanukul C; Sarsitthithum T; Vimolnoch M; Tawonwong T; Saksornchai K
    Radiat Oncol; 2022 Jan; 17(1):20. PubMed ID: 35093111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small-spot intensity-modulated proton therapy and volumetric-modulated arc therapies for patients with locally advanced non-small-cell lung cancer: A dosimetric comparative study.
    Liu C; Sio TT; Deng W; Shan J; Daniels TB; Rule WG; Lara PR; Korte SM; Shen J; Ding X; Schild SE; Bues M; Liu W
    J Appl Clin Med Phys; 2018 Nov; 19(6):140-148. PubMed ID: 30328674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of setup and range uncertainties on TCP and NTCP following VMAT or IMPT of oropharyngeal cancer patients.
    Hamming-Vrieze O; Depauw N; Craft DL; Chan AW; Rasch CRN; Verheij M; Sonke JJ; Kooy HM
    Phys Med Biol; 2019 Apr; 64(9):095001. PubMed ID: 30921775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statistical evaluation of worst-case robust optimization intensity-modulated proton therapy plans using an exhaustive sampling approach.
    Yang Z; Li H; Li Y; Li Y; Chang Y; Li Q; Yang K; Wu G; Sahoo N; Poenisch F; Gillin M; Zhu XR; Zhang X
    Radiat Oncol; 2019 Jul; 14(1):129. PubMed ID: 31324257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the normalized prescription isodose line on the magnitude of Monte Carlo vs. pencil beam target dose differences for lung stereotactic body radiotherapy.
    Zheng D; Zhang Q; Liang X; Zhu X; Verma V; Wang S; Zhou S
    J Appl Clin Med Phys; 2016 Jul; 17(4):48-58. PubMed ID: 27455476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of MRI-only treatment planning for proton therapy in brain and prostate cancers: Dose calculation accuracy in substitute CT images.
    Koivula L; Wee L; Korhonen J
    Med Phys; 2016 Aug; 43(8):4634. PubMed ID: 27487880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of different treatment planning approaches for intensity-modulated proton therapy with simultaneous integrated boost for pancreatic cancer.
    Stefanowicz S; Stützer K; Zschaeck S; Jakobi A; Troost EGC
    Radiat Oncol; 2018 Nov; 13(1):228. PubMed ID: 30466468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose uncertainties in IMPT for oropharyngeal cancer in the presence of anatomical, range, and setup errors.
    Kraan AC; van de Water S; Teguh DN; Al-Mamgani A; Madden T; Kooy HM; Heijmen BJ; Hoogeman MS
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):888-96. PubMed ID: 24351409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transitioning from measurement-based to combined patient-specific quality assurance for intensity-modulated proton therapy.
    Chen M; Yepes P; Hojo Y; Poenisch F; Li Y; Chen J; Xu C; He X; Gunn GB; Frank SJ; Sahoo N; Li H; Zhu XR; Zhang X
    Br J Radiol; 2020 Mar; 93(1107):20190669. PubMed ID: 31799859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.